Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment.
bioRxiv.
2024 Mar 7;. doi: 10.1101/2024.03.05.583586. PubMed PMID:
38496566; PubMed Central PMCID:
PMC10942289.
Does delayed EBV infection contribute to rising childhood cancers?.
Trends Immunol.
2022 Dec;43(12):956-958. doi: 10.1016/j.it.2022.09.009. Epub 2022 Oct 8. PubMed PMID:
36216720.
Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy.
Clin Cancer Res.
2022 Oct 14;28(20):4363-4369. doi: 10.1158/1078-0432.CCR-21-3408. Review. PubMed PMID:
35686929; PubMed Central PMCID:
PMC9714122.
Mechanism of EBV inducing anti-tumour immunity and its therapeutic use.
Nature.
2021 Feb;590(7844):157-162. doi: 10.1038/s41586-020-03075-w. Epub 2020 Dec 23. PubMed PMID:
33361812; PubMed Central PMCID:
PMC7864874.
BCR-dependent lineage plasticity in mature B cells.
Science.
2019 Feb 15;363(6428):748-753. doi: 10.1126/science.aau8475. PubMed PMID:
30765568.
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4(+) and CD8(+) T cell responses.
Proc Natl Acad Sci U S A.
2018 Jan 23;115(4):E686-E695. doi: 10.1073/pnas.1713607115. Epub 2018 Jan 8. PubMed PMID:
29311309; PubMed Central PMCID:
PMC5789919.
Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma.
Semin Cancer Biol.
2016 Aug;39:26-31. doi: 10.1016/j.semcancer.2016.08.001. Epub 2016 Aug 18. Review. PubMed PMID:
27546290.
A Rapid Embryonic Stem Cell-Based Mouse Model for B-cell Lymphomas Driven by Epstein-Barr Virus Protein LMP1.
Cancer Immunol Res.
2015 Jun;3(6):641-9. doi: 10.1158/2326-6066.CIR-15-0058. Epub 2015 May 1. PubMed PMID:
25934172; PubMed Central PMCID:
PMC4456688.
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
Cell Rep.
2015 May 5;11(5):715-26. doi: 10.1016/j.celrep.2015.03.059. Epub 2015 Apr 23. PubMed PMID:
25921526; PubMed Central PMCID:
PMC4426003.
Studying Epstein-Barr virus pathologies and immune surveillance by reconstructing EBV infection in mice.
Cold Spring Harb Symp Quant Biol.
2013;78:259-63. doi: 10.1101/sqb.2013.78.020222. Epub 2013 Nov 15. PubMed PMID:
24241423.
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.
Cancer Cell.
2012 Aug 14;22(2):167-79. doi: 10.1016/j.ccr.2012.06.012. PubMed PMID:
22897848; PubMed Central PMCID:
PMC3432451.
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.
Cell.
2012 Feb 17;148(4):739-51. doi: 10.1016/j.cell.2011.12.031. PubMed PMID:
22341446; PubMed Central PMCID:
PMC3313622.
Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma.
Cancer Cell.
2010 Dec 14;18(6):580-9. doi: 10.1016/j.ccr.2010.11.024. PubMed PMID:
21156282; PubMed Central PMCID:
PMC3018685.
Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.
Am J Pathol.
2010 Jun;176(6):2646-57. doi: 10.2353/ajpath.2010.090751. Epub 2010 Apr 2. PubMed PMID:
20363924; PubMed Central PMCID:
PMC2877828.
PI3 kinase signals BCR-dependent mature B cell survival.
Cell.
2009 Oct 30;139(3):573-86. doi: 10.1016/j.cell.2009.08.041. PubMed PMID:
19879843; PubMed Central PMCID:
PMC2787092.
NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
Proc Natl Acad Sci U S A.
2008 Aug 5;105(31):10883-8. doi: 10.1073/pnas.0805186105. Epub 2008 Jul 28. PubMed PMID:
18663224; PubMed Central PMCID:
PMC2504772.
Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.
J Biol Chem.
2008 Apr 18;283(16):10698-706. doi: 10.1074/jbc.M800806200. Epub 2008 Feb 15. PubMed PMID:
18281283; PubMed Central PMCID:
PMC3762532.
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.
Nat Immunol.
2008 Apr;9(4):405-14. doi: 10.1038/ni1575. Epub 2008 Mar 9. PubMed PMID:
18327259; PubMed Central PMCID:
PMC2533767.
NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.
Blood.
2007 Jul 15;110(2):743-51. doi: 10.1182/blood-2006-11-058446. Epub 2007 Apr 3. PubMed PMID:
17405906; PubMed Central PMCID:
PMC1924489.
NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells.
J Biol Chem.
2006 Dec 15;281(50):38617-24. doi: 10.1074/jbc.M606705200. Epub 2006 Oct 17. PubMed PMID:
17046818; PubMed Central PMCID:
PMC1847381.
What would you like to do?